Business description: TearLab Corporation

Sales by Activity: TearLab Corporation
| Fiscal Period: December | 2019 (USD) |
|---|---|
Diagnostic Kits / Equipment | 22.66M |
Geographical breakdown of sales: TearLab Corporation
| Fiscal Period: December | 2019 (USD) |
|---|---|
United States | 21.29M |
Rest of the World | 1.37M |
Executive Committee: TearLab Corporation
| Manager | Title | Age | Since |
|---|---|---|---|
Adam Szaronos
CEO | Chief Executive Officer | - | 2026-03-31 |
| Chief Tech/Sci/R&D Officer | - | 2009-07-16 | |
John Lund
DFI | Director of Finance/CFO | 60 | 2022-06-30 |
Steve Zmina
CTO | Chief Tech/Sci/R&D Officer | - | 2006-09-30 |
Michael Berg
CTO | Chief Tech/Sci/R&D Officer | 73 | - |
Composition of the Board of Directors: TearLab Corporation
| Director | Title | Age | Since |
|---|---|---|---|
Uri Geiger
BRD | Director/Board Member | 58 | 2020-07-08 |
James V. Mazzo
CHM | Chairman | 68 | 2021-12-08 |
| Director/Board Member | 78 | 2004-08-31 | |
Dolev Rafaeli
BRD | Director/Board Member | 62 | - |
Barak Azmon
BRD | Director/Board Member | - | - |
David Carter
BRD | Director/Board Member | - | - |
Douglas Strang
BRD | Director/Board Member | - | - |
Company details: TearLab Corporation

Glasses, Spectacles & Contact Lenses
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +1.56% | +2.41% | -14.09% | +12.32% | 184B | ||
| -6.38% | -4.98% | -18.07% | +8.01% | 112B | ||
| -0.59% | +1.18% | +6.44% | +36.82% | 118B | ||
| +3.42% | +1.71% | -41.92% | +8.01% | 94.58B | ||
| +0.09% | -0.05% | -2.06% | +78.69% | 63.13B | ||
| -0.46% | +0.42% | +4.48% | +82.84% | 55.66B | ||
| -0.23% | -0.52% | +10.73% | -21.72% | 53.9B | ||
| -4.30% | -1.64% | -12.44% | +37.99% | 43.42B | ||
| +0.58% | +2.00% | -1.17% | -8.82% | 34.68B | ||
| Average | -0.70% | +0.06% | -7.57% | +26.01% | 84.36B | |
| Weighted average by Cap. | -0.49% | +0.23% | -10.14% | +23.73% |

















